EUVIMEDEUVIMED entdecken
Crossref

Digital rectal examination as a standalone trigger for urgent prostate cancer investigation

R Varuni S, M Gado, P Pinnamaraju, W Hajuthman, R Dsouza, D Jadeja, G Smith, B Young, T Dewan, W Sheikh, Y Kathiresan, S Verma und 4 weitere

The Annals of The Royal College of Surgeons of England · 02.11.2026

DOI: 10.1308/rcsann.2026.0089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Annals of The Royal College of Surgeons of England, online erschienen am 02.11.2026. Verfasst von R Varuni S und 15 weiteren Autor:innen. Beteiligte Einrichtung: Northampton General Hospital NHS Trust, UK. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The contemporary value of digital rectal examination (DRE) as a standalone trigger for urgent prostate cancer investigation remains a subject of intense debate. Increasing scepticism regarding its diagnostic sensitivity, coupled with patient reluctance, has led to declining uptake of DRE in primary care. This study evaluates the outcomes of patients referred solely based on an abnormal DRE to determine its role in identifying clinically significant disease that might otherwise be overlooked by prostate-specific antigen (PSA) screening.

Methods

A retrospective analysis was conducted on 2,700 patients referred via the rapid prostate cancer pathway over a 33-month period. A specific cohort of 288 patients referred primarily because of an abnormal DRE finding – with PSA levels within the age-specific reference range – was identified.

Results

The mean patient age was 69 years and median PSA was 2.7ng/mL. Following secondary care assessment, 56.6% (163 of 288) of patients underwent biparametric magnetic resonance imaging. Of these, 35.5% had suspicious findings (Prostate Imaging–Reporting and Data System score ≥3). Ultimately, 14.2% (41 of 288) of patients underwent transperineal biopsy. Clinically significant prostate cancer was diagnosed in 16 patients (cancer detection rate: 5.6%); all 16 underwent radical treatment.

Conclusions

DRE should not be superseded by PSA testing alone. Rather, it should be offered as part of a comprehensive primary care assessment, with its use determined through shared decision making that balances clinical benefit against patient acceptability. An abnormal DRE, regardless of the PSA level, necessitates urgent referral to a rapid access urology pathway.

Schlagwörter

Stichwörter der Autor:innen

Biparametric MRI (bpMRI)Clinically significant prostate cancer (csPCa)Digital rectal examination (DRE)Prostate cancerProstate-specific antigen (PSA)Rapid access pathway

Autor:innen und Institutionen

  • Northampton General Hospital NHS Trust, UK.

Zitieren

APA

Varuni S, R., Gado, M., Pinnamaraju, P., Hajuthman, W., Dsouza, R., Jadeja, D., Smith, G., Young, B., Dewan, T., Sheikh, W., Kathiresan, Y., Verma, S., Eyong, R., Diya, M., Tharakan, T., & Pai, A. (2026). Digital rectal examination as a standalone trigger for urgent prostate cancer investigation. The Annals of The Royal College of Surgeons of England. https://doi.org/10.1308/rcsann.2026.0089

Vancouver

Varuni S R, Gado M, Pinnamaraju P, Hajuthman W, Dsouza R, Jadeja D, et al. Digital rectal examination as a standalone trigger for urgent prostate cancer investigation. The Annals of The Royal College of Surgeons of England. 2026. doi:10.1308/rcsann.2026.0089

BibTeX
@article{VaruniS2026,
  author = {Varuni S, R and Gado, M and Pinnamaraju, P and Hajuthman, W and Dsouza, R and Jadeja, D and Smith, G and Young, B and Dewan, T and Sheikh, W and Kathiresan, Y and Verma, S and Eyong, R and Diya, M and Tharakan, T and Pai, A},
  title = {Digital rectal examination as a standalone trigger for urgent prostate cancer investigation},
  journal = {The Annals of The Royal College of Surgeons of England},
  year = {2026},
  doi = {10.1308/rcsann.2026.0089}
}
Kostenlos starten →